In July, the SARS-CoV-2 virus has returned to the top among respiratory viruses detected in China, surpassing influenza. Recent weeks have seen an increase in infections, prompting international attention, though experts reassure that this is not an emergency situation like during the early pandemic years. According to data from the Chinese Center for Disease Control and Prevention, approximately 79,000 confirmed cases were recorded in June, with 130 severe cases and one death involving a person with pre-existing conditions. The positivity rate among symptomatic patients has risen from 16.3% in mid-July to over 20% in the following week. Infections are higher in southern provinces, primarily affecting individuals aged 15 to 59. The resurgence is attributed mainly to the Omicron variant NB.1.8.1, which has moderate increased transmissibility but does not show greater clinical severity. Most patients experience mild symptoms such as fever, sore throat, and cold, recovering within five to seven days. Experts note that the virus now circulates year-round, leading to summer waves due to factors like prolonged use of air-conditioned environments, holiday travel, and waning immunity after
Bias read (Center): The article presents factual information about the resurgence of COVID-19 in China, including data from official sources and expert opinions. It avoids taking a clear stance on the implications of the outbreak, focusing on providing context and comparisons rather than emphasizing any particular side





